De Burlo Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.7M | Buy |
48,765
+30
| +0.1% | +$13.4K | 2.86% | 13 |
|
|
2025
Q1 | $23.6M | Hold |
48,735
| – | – | 3.49% | 8 |
|
|
2024
Q4 | $19.6M | Sell |
48,735
-460
| -0.9% | -$185K | 2.62% | 15 |
|
|
2024
Q3 | $22.9M | Buy |
49,195
+630
| +1% | +$293K | 2.82% | 12 |
|
|
2024
Q2 | $22.8M | Buy |
48,565
+8,525
| +21% | +$4M | 3.06% | 14 |
|
|
2024
Q1 | $16.7M | Sell |
40,040
-24,725
| -38% | -$10.3M | 2.22% | 21 |
|
|
2023
Q4 | $22.5M | Hold |
64,765
| – | – | 3.91% | 9 |
|
|
2023
Q3 | $22.5M | Buy |
64,765
+715
| +1% | +$249K | 3.91% | 9 |
|
|
2023
Q2 | $22.5M | Buy |
64,050
+8,310
| +15% | +$2.92M | 3.75% | 6 |
|
|
2023
Q1 | $17.6M | Hold |
55,740
| – | – | 3.43% | 6 |
|
|
2022
Q4 | $16.1M | Sell |
55,740
-6,680
| -11% | -$1.93M | 3.6% | 9 |
|
|
2022
Q3 | $18.1M | Buy |
+62,420
| New | +$18.1M | 4.3% | 5 |
|
|
2022
Q2 | – | Sell |
-68,410
| Closed | -$17.9M | – | 195 |
|
|
2022
Q1 | $17.9M | Buy |
+68,410
| New | +$17.9M | 3.32% | 10 |
|
|
2020
Q4 | – | Sell |
-810
| Closed | -$220K | – | 96 |
|
|
2020
Q3 | $220K | Sell |
810
-74,110
| -99% | -$20.1M | 0.04% | 81 |
|
|
2020
Q2 | $17.8M | Hold |
74,920
| – | – | 5% | 4 |
|
|
2020
Q1 | $17.8M | Buy |
74,920
+920
| +1% | +$219K | 5% | 4 |
|
|
2019
Q4 | $16.2M | Buy |
+74,000
| New | +$16.2M | 3.27% | 8 |
|
|
2018
Q2 | – | Sell |
-44,800
| Closed | -$7.3M | – | 118 |
|
|
2018
Q1 | $7.3M | Buy |
44,800
+26,900
| +150% | +$4.38M | 1.59% | 24 |
|
|
2017
Q4 | $2.68M | Sell |
17,900
-17,700
| -50% | -$2.65M | 0.54% | 52 |
|
|
2017
Q3 | $5.41M | Buy |
+35,600
| New | +$5.41M | 1.2% | 31 |
|